Actively Recruiting
A Clinico-biological Database of Lung Cancers
Led by University Hospital, Lille · Updated on 2022-10-19
500
Participants Needed
1
Research Sites
676 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Lille
Lead Sponsor
I
Institut Pasteur de Lille
Collaborating Sponsor
AI-Summary
What this Trial Is About
This prospective, single-center, interventional study is conducted in order to achieve a biological bank accompanied by clinical data. Blood samples, optional tumor tissue and fecal samples are collected, processed and banked for all the included subjects. Those samples are collected before the start of treatment, at the time of first tumor assessment, at the time of first and second disease progression. The subjects are treated according to standard of care. Clinical data are collected at each sampling time. The primary objective of the study is to identify biological, clinical and tumoral factors associated with tumor response according SOC treatment.
CONDITIONS
Official Title
A Clinico-biological Database of Lung Cancers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Documented new diagnosis of lung cancer by histology or cytology, or lung tumor suspected to be cancer requiring antineoplastic treatment
- Indication for first-line lung cancer treatment by surgery, chemotherapy, radio-chemotherapy, radiotherapy, or targeted therapy
- Ability to follow study procedures
- Age over 18 years
- At least one measurable or assessable lesion according to RECIST 1.1 criteria
- Registered with a social security scheme
- Receiving care at Pneumology department of Lille University Hospital
- Signed informed consent form
You will not qualify if you...
- History of treatment with antineoplastic chemotherapy, radio-chemotherapy, radiotherapy, or targeted therapy, or contraindication to antineoplastic treatment
- Unwillingness to sign informed consent form
- Not registered with a social security scheme
- Not francophone
- Deprived of liberty or under trusteeship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital Calmette, CHU
Lille, France
Actively Recruiting
Research Team
A
Alexis CORTOT, MD,PhD
CONTACT
E
Eric WASIELEWSKI, M
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here